QIPT · As filed with the SEC
Quipt Home Medical cash flow statement, by quarter
The statement as Quipt Home Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) · USD
| USD | Q1 FY26 3 months ended Dec 31, 2025 | Q4 FY25 3 months ended Sep 30, 2025 | Q3 FY25 3 months ended Jun 30, 2025 | Q2 FY25 3 months ended Mar 31, 2025 |
|---|---|---|---|---|
| Operating activities | ||||
| Net income (loss) | (1,053,000) | — | — | — |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||
| Net income attributable to noncontrolling interest | 339,000 | — | — | — |
| Depreciation and amortization | 12,553,000 | — | — | — |
| Right-of-use operating lease amortization and interest | 1,869,000 | — | — | — |
| Payments of operating leases, including interest | (1,823,000) | — | — | — |
| Stock-based compensation | 982,000 | — | — | — |
| Gain on disposals of property and equipment | (70,000) | — | — | — |
| Amortization of financing costs and accretion of purchase price payable | 123,000 | — | — | — |
| Change in fair value of derivative liability - interest rate swaps | (24,000) | — | — | — |
| Loss (gain) on foreign currency transactions | (73,000) | — | — | — |
| Share of loss in equity method investment | 46,000 | — | — | — |
| Change in working capital: | ||||
| Net decrease (increase) in accounts receivable | (223,000) | — | — | — |
| Net decrease (increase) in inventory | (1,282,000) | — | — | — |
| Net decrease (increase) in prepaid and other current assets | (633,000) | — | — | — |
| Net decrease in deferred revenue | (162,000) | — | — | — |
| Net decrease in accounts payables and accrued liabilities | (1,628,000) | — | — | — |
| Net cash flow provided by operating activities | 8,941,000 | — | — | — |
| Investing activities | ||||
| Purchases of property and equipment | (2,074,000) | — | — | — |
| Cash proceeds from sale of property and equipment | 126,000 | — | — | — |
| Net cash flow used in investing activities | (1,948,000) | — | — | — |
| Financing activities | ||||
| Repayments of equipment loans | (6,159,000) | — | — | — |
| Repayments of finance leases | (322,000) | — | — | — |
| Repayments of senior credit facility | (1,080,000) | — | — | — |
| Gross repayments on the revolving credit facility | (2,507,000) | — | — | — |
| Exercise of stock options | 629,000 | — | — | — |
| Net cash flow used in financing activities | (9,439,000) | — | — | — |
| Effect of exchange rate changes on cash held in foreign currencies | 73,000 | — | — | — |
| Net decrease in cash | (2,373,000) | — | — | — |
| Cash, beginning of period | 12,916,000 | 11,250,000 | 17,145,000 | 15,451,000 |
| Cash, end of period | 10,543,000 | 12,916,000 | 11,250,000 | 17,145,000 |
| Supplemental cash flow information | ||||
| Cash paid for interest | (1,734,000) | — | — | — |
| Cash refunded for income taxes | 252,000 | — | — | — |
| Operating lease additions | 1,305,000 | — | — | — |
| Equipment loan additions | 6,261,000 | — | — | — |
| Finance lease additions | 93,000 | — | — | — |
| Purchases of property and equipment in ending accounts payable | 2,094,000 | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.